Glyceryl triacetate

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
307	カナバン病	2

307. カナバン病

臨床試験数 : 6 / 薬物数 : 11 - (DrugBank : 5) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 2

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00657748 (ClinicalTrials.gov)	September 2009	9/4/2008	Lithium and Acetate for Canavan Disease	Evaluation of the Tolerance and Efficiency of a Combined Oral Therapy With Lithium and GTA in Patien ...	Canavan Disease;Infantile;Deficiency Disease;Aspartoacylase;Leukodystrophy, Spongiform	Drug: Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)	Assistance Publique - Hôpitaux de Paris	European Leukodystrophy Association;European Leukodystrophy Association	Withdrawn	1 Year	15 Years	Both	0	Phase 2	France
2	NCT00724802 (ClinicalTrials.gov)	March 2008	18/6/2008	Oral Glyceryl Triacetate (GTA) in Newborns With Canavan	Oral Glyceryl Triacetate (GTA) in Newborns With Canavan	Canavan Disease	Dietary Supplement: GTA (Glyceryl triacetate);Drug: GTA glyceryl triacetate	Shaare Zedek Medical Center	NULL	Recruiting	N/A	18 Months	Both	1	N/A	Israel

First Previous1Next Last